Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pope Leo XIV Signals Continuity on LGBTQ Outreach: What Christians Should Watch

Recent comments by Jesuit priest Father James Martin have renewed…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Softening the Words of Jesus: The Dangerous Drift of Modern Christianity

When Doctrine Is Dismissed, Truth Is at Risk Why the Bible’s…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Guard Your Heart: The End Time Generation’s Wake-Up Call

Solomon’s Slow Drift — and Ours Solomon didn’t wake up…
Read more